Skip to content

Construction of a Prediction Model for Postoperative Transient Neurological Deficits in Patients with Moyamoya Disease Based on Machine Learning

Construction of a Prediction Model for Postoperative Transient Neurological Deficits in Patients with Moyamoya Disease Based on Machine Learning

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500114788
Enrollment
Unknown
Registered
2025-12-17
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

moyamoya disease

Interventions

Sponsors

Beijing Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 18 and 65; 2. Diagnosed with Moyamoya disease, the diagnostic criteria comply with the "Chinese Expert Consensus on the Diagnosis and Treatment of Moyamoya Disease and Moyamoya Syndrome (2024 Edition)" : (1) Stenosis or occlusion of the terminal segment of the internal carotid artery and the initial segments of the middle cerebral artery and anterior cerebral artery; (2) Abnormal vascular networks appear at the base of the skull; (3) Bilateral or unilateral involvement. Simultaneously meet the conditions of (1) and (3) or (2) and (3), and rule out cerebral atherosclerosis, autoimmune diseases, meningitis, craniocerebral trauma, radiation injury, brain tumors, etc. 3. Those with complete clinical data; 4. No cerebral revascularization surgery was performed in another hospital before admission; 5. The symptoms of neurological deficit occurred within 2 weeks after the operation, and the symptoms fully recovered or significantly improved within 2 weeks after the operation.

Exclusion criteria

Exclusion criteria: 1. Patients with mental disorders or those with a history of mental illness either personally or in their families; 2. Combined with other serious liver and kidney diseases or malignant tumors.

Design outcomes

Primary

MeasureTime frame
Postoperative complications;model differential validity;model Hosmer-Lemeshow test;

Countries

China

Contacts

Public ContactHuang Shan

Beijing Hospital

huangshan6206@bjhmoh.cn+86 10 8513 6191

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026